We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKE icon
701
Park Aerospace
PKE
$732M
$463K ﹤0.01%
+16,902
New +$433K
QNST icon
702
QuinStreet
QNST
$933M
$463K ﹤0.01%
+38,517
New +$488K
JBS
703
JBS N.V.
JBS
$39.3B
$462K ﹤0.01%
25,733
-2,241
-8% -$34.9K
AUPH icon
704
Aurinia Pharmaceuticals
AUPH
$2.01B
$462K ﹤0.01%
31,167
-677
-2% -$9.89K
CART icon
705
Maplebear
CART
$10.7B
$461K ﹤0.01%
12,302
+1,023
+9% +$38.8K
PTCT icon
706
PTC Therapeutics
PTCT
$6.51B
$461K ﹤0.01%
6,764
+2,417
+56% +$171K
TNK icon
707
Teekay Tankers
TNK
$2.62B
$458K ﹤0.01%
6,253
-2,202
-26% -$147K
ARWR icon
708
Arrowhead Research
ARWR
$10.5B
$457K ﹤0.01%
+7,294
New +$462K
TK icon
709
Teekay
TK
$986M
$456K ﹤0.01%
37,379
-12,671
-25% -$140K
XPEL icon
710
XPEL
XPEL
$1.18B
$456K ﹤0.01%
10,305
-104
-1% -$4.97K
FRSH icon
711
Freshworks
FRSH
$2.96B
$456K ﹤0.01%
+56,734
New +$523K
IESC icon
712
IES Holdings
IESC
$12.9B
$455K ﹤0.01%
955
-278
-23% -$127K
PAX icon
713
Patria Investments
PAX
$1.78B
$454K ﹤0.01%
36,053
+3,855
+12% +$54.2K
BMI icon
714
Badger Meter
BMI
$4.26B
$453K ﹤0.01%
2,974
+206
+7% +$32.3K
GIC icon
715
Global Industrial
GIC
$1.32B
$453K ﹤0.01%
14,365
-2,749
-16% -$86.5K
ACAD icon
716
Acadia Pharmaceuticals
ACAD
$4.35B
$452K ﹤0.01%
20,302
+991
+5% +$23.7K
NATH icon
717
Nathan's Famous
NATH
$401M
$451K ﹤0.01%
4,482
-637
-12% -$63.1K
FN icon
718
Fabrinet
FN
$18.9B
$448K ﹤0.01%
859
-275
-24% -$140K
LQDT icon
719
Liquidity Services
LQDT
$1.21B
$448K ﹤0.01%
14,645
-3,011
-17% -$93.7K
IDT icon
720
IDT Corp
IDT
$1.58B
$447K ﹤0.01%
9,113
-526
-5% -$26K
NRDS icon
721
NerdWallet
NRDS
$600M
$446K ﹤0.01%
43,008
+9,668
+29% +$109K
EVER icon
722
EverQuote
EVER
$952M
$446K ﹤0.01%
28,918
+10,141
+54% +$192K
OSPN icon
723
OneSpan
OSPN
$572M
$445K ﹤0.01%
42,297
+2,914
+7% +$33.1K
BLBD icon
724
Blue Bird Corp
BLBD
$2.57B
$445K ﹤0.01%
7,836
-1,680
-18% -$90.6K
CRMD icon
725
CorMedix
CRMD
$643M
$445K ﹤0.01%
65,490
+19,425
+42% +$144K

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.